Scarica l'app Stockscreener
7.95
1.15%
0.09
Dopo l'orario di chiusura:
7.93
-0.02
-0.25%
Precedente Chiudi:
$7.86
Aprire:
$8
Volume 24 ore:
103.47K
Relative Volume:
1.28
Capitalizzazione di mercato:
$458.57M
Reddito:
$154.57M
Utile/perdita netta:
$15.07M
Rapporto P/E:
29.44
EPS:
0.27
Flusso di cassa netto:
$10.92M
1 W Prestazione:
+12.61%
1M Prestazione:
+18.13%
6M Prestazione:
+3.25%
1 anno Prestazione:
+8.61%
Intervallo 1D:
$7.905
$8.0599
Intervallo di 1 settimana:
$6.92
$8.0599
Portata 52W:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Confronta KMDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.95 | 453.38M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
126.85 | 55.38B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.37 | 50.23B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.04 | 44.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.51 | 37.17B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
490.83 | 21.69B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | The Benchmark Company | Buy |
| 2024-07-03 | Iniziato | Stifel | Buy |
| 2018-02-02 | Iniziato | Chardan Capital Markets | Buy |
Kamada Ltd Borsa (KMDA) Ultime notizie
Can Kamada Ltd. stock attract ESG capital inflowsMarket Performance Recap & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Benchmark reiterates Buy rating on Kamada stock, maintains $15 target By Investing.com - Investing.com Nigeria
Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers (NASDAQ:KMDA) - Seeking Alpha
Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus
Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN
Kamada stock rises after issuing 2026 guidance showing double-digit growth - Investing.com Canada
Kamada forecasts 13% revenue growth in 2026, issues guidance By Investing.com - Investing.com Nigeria
Kamada Provides 2026 Annual Guidance of $200$205 Million - GlobeNewswire
Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Kamada Ltd. (KMDA) Stock Analysis: Unearthing an 84% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Leasing LimitedFundamental Strength Indicators & Free Exceptional ROI Methods - bollywoodhelpline.com
Kamada stock rises after issuing 2026 guidance showing double-digit growth By Investing.com - Investing.com South Africa
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World
Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN
Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga
Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com
Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда
Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда
Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда
Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber
Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks
Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда
Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда
Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria
Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com
Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com
Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks
Kamada secures $10-14 million Canadian supply tender extension - Investing.com
Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire
Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn
Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily
Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World
FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World
What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat
Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World
Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks
Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa
Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga
Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com
Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks
Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks
Kamada Ltd Azioni (KMDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.41%
1.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):